REPAGLINIDE
- Product NDC
- 51991-855
- 11-digit product format
- 519910855
- Labeler code
- 51991
- Product ID
- 51991-855_d791eddc-7e75-42af-946b-5c67ddbad99e
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- REPAGLINIDE
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Breckenridge Pharmaceutical, Inc.
- Application
- ANDA091517
- Marketing category
- ANDA
- Marketing start
- 2015-05-01
- Marketing end
- 2022-04-30
- Substance
- REPAGLINIDE
- Active strength
- 2 mg/1
- Pharmacologic classes
- Glinide [EPC],Potassium Channel Antagonists [MoA]
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 51991-855-01 | 51991085501 | 100 TABLET in 1 BOTTLE (51991-855-01) | 100 tablet | 2015-05-01 | 2022-04-30 | No | No | Current |